7ZEH | pdb_00007zeh

Human cytosolic 5' nucleotidase IIIB in complex with 3,4-diF-Bn7Guanine


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.50 Å
  • R-Value Free: 
    0.220 (Depositor), 0.218 (DCC) 
  • R-Value Work: 
    0.188 (Depositor), 0.185 (DCC) 
  • R-Value Observed: 
    0.189 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 7ZEH

Ligand Structure Quality Assessment 


This is version 1.3 of the entry. See complete history

Literature

Substrate-Based Design of Cytosolic Nucleotidase IIIB Inhibitors and Structural Insights into Inhibition Mechanism.

Kubacka, D.Kozarski, M.Baranowski, M.R.Wojcik, R.Panecka-Hofman, J.Strzelecka, D.Basquin, J.Jemielity, J.Kowalska, J.

(2022) Pharmaceuticals (Basel) 15

  • DOI: https://doi.org/10.3390/ph15050554
  • Primary Citation Related Structures: 
    7ZEE, 7ZEG, 7ZEH

  • PubMed Abstract: 

    Cytosolic nucleotidases (cNs) catalyze dephosphorylation of nucleoside 5'-monophosphates and thereby contribute to the regulation of nucleotide levels in cells. cNs have also been shown to dephosphorylate several therapeutically relevant nucleotide analogues. cN-IIIB has shown in vitro a distinctive activity towards 7-mehtylguanosine monophosphate (m 7 GMP), which is one key metabolites of mRNA cap. Consequently, it has been proposed that cN-IIIB participates in mRNA cap turnover and prevents undesired accumulation and salvage of m 7 GMP. Here, we sought to develop molecular tools enabling more advanced studies on the cellular role of cN-IIIB. To that end, we performed substrate and inhibitor property profiling using a library of 41 substrate analogs. The most potent hit compounds (identified among m 7 GMP analogs) were used as a starting point for structure-activity relationship studies. As a result, we identified several 7-benzylguanosine 5'-monophosphate (Bn 7 GMP) derivatives as potent, unhydrolyzable cN-IIIB inhibitors. The mechanism of inhibition was elucidated using X-ray crystallography and molecular docking. Finally, we showed that compounds that potently inhibit recombinant cN-IIIB have the ability to inhibit m 7 GMP decay in cell lysates.


  • Organizational Affiliation
    • Division of Biophysics, Institute of Experimental Physics, Faculty of Physics, University of Warsaw, Pasteura 5, 02-093 Warsaw, Poland.

Macromolecule Content 

  • Total Structure Weight: 143.08 kDa 
  • Atom Count: 10,071 
  • Modeled Residue Count: 1,104 
  • Deposited Residue Count: 1,208 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
7-methylguanosine phosphate-specific 5'-nucleotidase
A, B, C, D
302Homo sapiensMutation(s): 0 
Gene Names: NT5C3BNT5C3L
EC: 3.1.3.91 (PDB Primary Data), 3.1.3.5 (PDB Primary Data)
UniProt & NIH Common Fund Data Resources
Find proteins for Q969T7 (Homo sapiens)
Explore Q969T7 
Go to UniProtKB:  Q969T7
PHAROS:  Q969T7
GTEx:  ENSG00000141698 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupQ969T7
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 6 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
IPQ
(Subject of Investigation/LOI)

Query on IPQ



Download:Ideal Coordinates CCD File
E [auth A],
P [auth B],
PA [auth D],
Z [auth C]
N7-(3,4-difluorobenzyl) guanine
C12 H10 F2 N5 O
NBTRICCNNMIXFE-UHFFFAOYSA-O
RBL
(Subject of Investigation/LOI)

Query on RBL



Download:Ideal Coordinates CCD File
AA [auth C],
F [auth A],
Q [auth B],
QA [auth D]
D-ribulose
C5 H10 O5
ZAQJHHRNXZUBTE-NQXXGFSBSA-N
SO4

Query on SO4



Download:Ideal Coordinates CCD File
AB [auth D],
NA [auth C],
O [auth A],
Y [auth B]
SULFATE ION
O4 S
QAOWNCQODCNURD-UHFFFAOYSA-L
PO4

Query on PO4



Download:Ideal Coordinates CCD File
MA [auth C],
N [auth A],
X [auth B],
ZA [auth D]
PHOSPHATE ION
O4 P
NBIIXXVUZAFLBC-UHFFFAOYSA-K
EDO

Query on EDO



Download:Ideal Coordinates CCD File
BA [auth C]
CA [auth C]
DA [auth C]
EA [auth C]
FA [auth C]
BA [auth C],
CA [auth C],
DA [auth C],
EA [auth C],
FA [auth C],
G [auth A],
GA [auth C],
H [auth A],
HA [auth C],
I [auth A],
IA [auth C],
J [auth A],
JA [auth C],
K [auth A],
KA [auth C],
L [auth A],
OA [auth D],
R [auth B],
RA [auth D],
S [auth B],
SA [auth D],
T [auth B],
TA [auth D],
U [auth B],
UA [auth D],
V [auth B],
VA [auth D],
WA [auth D],
XA [auth D]
1,2-ETHANEDIOL
C2 H6 O2
LYCAIKOWRPUZTN-UHFFFAOYSA-N
MG

Query on MG



Download:Ideal Coordinates CCD File
LA [auth C],
M [auth A],
W [auth B],
YA [auth D]
MAGNESIUM ION
Mg
JLVVSXFLKOJNIY-UHFFFAOYSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.50 Å
  • R-Value Free:  0.220 (Depositor), 0.218 (DCC) 
  • R-Value Work:  0.188 (Depositor), 0.185 (DCC) 
  • R-Value Observed: 0.189 (Depositor) 
Space Group: P 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 60.59α = 82.219
b = 80.89β = 72.462
c = 83.17γ = 68.202
Software Package:
Software NamePurpose
PHENIXrefinement
XDSdata reduction
XSCALEdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Polish National Science CentrePolandUMO- 2017/24/C/NZ1/00169

Revision History  (Full details and data files)

  • Version 1.0: 2022-05-25
    Type: Initial release
  • Version 1.1: 2022-06-08
    Changes: Database references
  • Version 1.2: 2024-01-31
    Changes: Data collection, Refinement description
  • Version 1.3: 2024-11-06
    Changes: Structure summary